OnKure Therapeutics Inc Sustainability Reports
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers of cancer. The company utilizes a structure-based drug design platform to advance its pipeline, notably targeting oncogenic PI3Kα with its flagship candidate OKI-219.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00JVRSRD0
1 reports from 2024 to 2024
